Advanced search
Publication Cover
Molecular and Cellular Biology Volume 24, 2004 - Issue 10
Submit an article Journal homepage
49
Views
165
CrossRef citations to date
0
Altmetric
Cell Growth and Development

Nuclear Export of Phosphorylated Galectin-3 Regulates Its Antiapoptotic Activity in Response to Chemotherapeutic Drugs

Yukinori Takenaka1 Tumor Progression and Metastasis Program, Karmanos Cancer Institute
,
Tomoharu Fukumori1 Tumor Progression and Metastasis Program, Karmanos Cancer Institute
,
Tadashi Yoshii2 Department of Otolaryngology and Sensory Organ Surgery, Osaka University Graduate School of Medicine, Suita, Osaka565-0871, Japan
,
Natsuo Oka1 Tumor Progression and Metastasis Program, Karmanos Cancer Institute
,
Hidenori Inohara2 Department of Otolaryngology and Sensory Organ Surgery, Osaka University Graduate School of Medicine, Suita, Osaka565-0871, Japan
,
Hyeong-Reh Choi Kim3 Department of Pathology, Wayne State University, Detroit, Michigan48201
,
Robert S. Bresalier4 Department of Gastrointestinal Medicine and Nutrition, The University of Texas M. D. Anderson Cancer Center, Houston, Texas77030
&
Avraham Raz1 Tumor Progression and Metastasis Program, Karmanos Cancer InstituteCorrespondence[email protected]
 show all
Pages 4395-4406 | Received 04 Nov 2003, Accepted 18 Feb 2004, Published online: 27 Mar 2023

Citations (165)

Keep up to date with the latest research on this topic with citation updates for this article.

Subscribe to citation updates

Read on this site (6)

Hepan Zhu, Yi Yang, Li Wang, Xiaobin Xu, Tingting Wang & Haoran Qian. (2020) Leptomycin B inhibits the proliferation, migration, and invasion of cultured gastric carcinoma cells. Bioscience, Biotechnology, and Biochemistry 84:2, pages 290-296.
Read now
Helen Blanchard, Xing Yu, Patrick Michael Collins & Khuchtumur Bum-Erdene. (2014) Galectin-3 inhibitors: a patent review (2008–present). Expert Opinion on Therapeutic Patents 24:10, pages 1053-1065.
Read now
Leonardo Mirandola, Diane D. Nguyen, Rakhshanda L. Rahman, Fabio Grizzi, Yu Yuefei, José A. Figueroa, Marjorie R. Jenkins, Everardo Cobos & Maurizio Chiriva-Internati. (2014) Anti-Galectin-3 Therapy: A New Chance for Multiple Myeloma and Ovarian Cancer?. International Reviews of Immunology 33:5, pages 417-427.
Read now
Yangyang Xu, Xin Gu, Mancheng Gong, Guiying Guo, Kaiyu Han & Ruihua An. (2013) Galectin-3 inhibition sensitizes human renal cell carcinoma cells to arsenic trioxide treatment. Cancer Biology & Therapy 14:10, pages 897-906.
Read now
Yves St-Pierre, Katherine Biron-Pain, Carole Campion, Geneviève Lavoie, Frédéric Bouchard & Julie Couillard. (2009) Potential directions for drug development against galectin-7 in cancer. Expert Opinion on Drug Discovery 4:6, pages 611-620.
Read now
Barbara Cecchinelli, Luca Lavra, Cinzia Rinaldo, Stefano Iacovelli, Aymone Gurtner, Alessandra Gasbarri, Alessandra Ulivieri, Fabrizio Del Prete, Maria Trovato, Giulia Piaggio, Armando Bartolazzi, Silvia Soddu & Salvatore Sciacchitano. (2006) Repression of the Antiapoptotic Molecule Galectin-3 by Homeodomain-Interacting Protein Kinase 2-Activated p53 Is Required for p53-Induced Apoptosis. Molecular and Cellular Biology 26:12, pages 4746-4757.
Read now

Articles from other publishers (159)

Sofia Nascimento dos Santos, Dino Seigo Gushiken Junior, Jhonatas Pedrosa Marim Pereira, Natália Miranda Iadocicco, André Henrique Silva, Tatielle do Nascimento, Luís Alberto Pereira Dias, Flávia Rodrigues de Oliveira Silva, Eduardo Ricci-Junior, Ralph Santos-Oliveira & Emerson Soares Bernardes. (2023) Development of glycan-targeted nanoparticles as a novel therapeutic opportunity for gastric cancer treatment. Cancer Nanotechnology 14:1.
Crossref
Rakin Ahmed, Khairul Anam & Hafiz Ahmed. (2023) Development of Galectin-3 Targeting Drugs for Therapeutic Applications in Various Diseases. International Journal of Molecular Sciences 24:9, pages 8116.
Crossref
Diego D. Santos, Gisela R.S. Sasso, Nycole M. Belote, Rafael André da Silva, Izabella Lice, Rebeca D. Correia-Silva, Fernanda T. Borges, Adriana A.F. Carbonel & Cristiane D. Gil. (2023) Galectin-3 is a key hepatoprotective molecule against the deleterious effect of cisplatin. Life Sciences 318, pages 121505.
Crossref
Devaraj Ezhilarasan. (2023) Unraveling the pathophysiologic role of galectin‐3 in chronically injured liver. Journal of Cellular Physiology 238:4, pages 673-686.
Crossref
Tânia Lima, Luís Perpétuo, Rui Henrique, Margarida Fardilha, Adelino Leite-Moreira, Jose Bastos & Rui Vitorino. (2022) Galectin-3 in prostate cancer and heart diseases: a biomarker for these two frightening pathologies?. Molecular Biology Reports 50:3, pages 2763-2778.
Crossref
Tânia Lima, Catarina Macedo-Silva, Diana Felizardo, João Fraga, Isa Carneiro, Carmen Jerónimo, Rui Henrique, Margarida Fardilha & Rui Vitorino. (2023) Gal-3 Protein Expression and Localization in Prostate Tumours. Current Oncology 30:3, pages 2729-2742.
Crossref
Linus Kruk, Attila Braun, Erika Cosset, Thomas Gudermann & Elmina Mammadova-Bach. (2023) Galectin functions in cancer-associated inflammation and thrombosis. Frontiers in Cardiovascular Medicine 10.
Crossref
Norhan B.B. Mohammed, Aristotelis Antonopoulos, Anne Dell, Stuart M. Haslam & Charles J. Dimitroff. 2023. Novel Methods and Pathways in Cancer Glycobiology Research. Novel Methods and Pathways in Cancer Glycobiology Research 157 193 .
Kelvin Wei Zhern Loh, Zhenyu Hu & Tuck Wah Soong. 2023.
Tânia Lima, Rita Ferreira, Marina Freitas, Rui Henrique, Rui Vitorino & Margarida Fardilha. (2022) Integration of Automatic Text Mining and Genomic and Proteomic Analysis to Unravel Prostate Cancer Biomarkers. Journal of Proteome Research 21:2, pages 447-458.
Crossref
Oliver Dräger, Klaus Metz, Maike Busch & Nicole Dünker. (2021) Role of L1CAM in retinoblastoma tumorigenesis: identification of novel therapeutic targets. Molecular Oncology 16:4, pages 957-981.
Crossref
Hans Verkerke, Marcelo Dias-Baruffi, Richard D. Cummings, Connie M. Arthur & Sean R. Stowell. 2022. Galectins. Galectins 1 40 .
Sibel Özdaş & İpek Canatar. (2021) Targeting of nucleo‑cytoplasmic transport factor exportin 1 in malignancy. Medicine International 2:1.
Crossref
Samy Ajarrag & Yves St-Pierre. (2021) Galectins in Glioma: Current Roles in Cancer Progression and Future Directions for Improving Treatment. Cancers 13:21, pages 5533.
Crossref
Misako Nagasaka, Mohammad Fahad B. Asad, Mohammed Najeeb Al Hallak, Md. Hafiz Uddin, Ammar Sukari, Yasmine Baca, Joanne Xiu, Dan Magee, Hirva Mamdani, Dipesh Uprety, Chul Kim, Bing Xia, Stephen V. Liu, Jorge J. Nieva, Gilberto Lopes, Gerold Bepler, Hossein Borghaei, Michael J. Demeure, Luis E. Raez, Patrick C. Ma, Sonam Puri, W Michael Korn & Asfar S. Azmi. (2021) Impact of XPO1 mutations on survival outcomes in metastatic non-small cell lung cancer (NSCLC). Lung Cancer 160, pages 92-98.
Crossref
Thiago Henrique M. Vargas, Camila N. Barra, Lidia H. Pulz, Greice C. Huete, Karine G. Cadrobbi, Adriana Tomoko Nishiya, Silvia Regina Kleeb, José Guilherme Xavier, José Luiz Catão-Dias & Ricardo F. Strefezzi. (2021) Galectin-3 immunolabelling correlates with BCL2 expression in canine cutaneous mast cell tumours. Acta Veterinaria Hungarica 69:2, pages 169-174.
Crossref
Mourad Zerfaoui, Titilope Modupe Dokunmu, Eman Ali Toraih, Bashir M. Rezk, Zakaria Y. Abd Elmageed & Emad Kandil. (2021) New Insights into the Link between Melanoma and Thyroid Cancer: Role of Nucleocytoplasmic Trafficking. Cells 10:2, pages 367.
Crossref
Scott A. Barman, Zsuzsanna Bordan, Robert Batori, Stephen Haigh & David J. R. Fulton. 2021. Lung Inflammation in Health and Disease, Volume I. Lung Inflammation in Health and Disease, Volume I 13 32 .
Pilar Navarro, Neus Martínez-Bosch, Ada G. Blidner & Gabriel A. Rabinovich. (2020) Impact of Galectins in Resistance to Anticancer Therapies. Clinical Cancer Research 26:23, pages 6086-6101.
Crossref
Jie Ji, Xue Cheng, Wei Wang & Jingmin Zhang. (2020) Vitamin D regulates cell viability, migration and proliferation by suppressing galectin-3 (Gal-3) gene in ovarian cancer cells. Journal of Biosciences 45:1.
Crossref
Michelle de Oliveira Chain, Cefas Augusto de Medeiros Paiva, Igor Oliveira Maciel, Alberto Nogueira Neto, Vitória Fernandes de Castro, Caroline Pacheco de Oliveira, Bruna dos Santos Mendonça, Gabriela Nestal de Moraes, Sheila Albert dos Reis, Marcelo Alex de Carvalho & Luiz Dione Barbosa De-Melo. (2020) Galectin-3 mediates survival and apoptosis pathways during Trypanosoma cruzi–host cell interplay. Experimental Parasitology 216, pages 107932.
Crossref
Qiuyi Li & Yuan Huang. (2020) Mitochondrial targeted strategies and their application for cancer and other diseases treatment. Journal of Pharmaceutical Investigation 50:3, pages 271-293.
Crossref
Brooke V. Hisrich, R. Brant Young, Alison M. Sansone, Zachary Bowens, Lisa J. Green, Bruce A. Lessey & Anna V. Blenda. (2020) Role of Human Galectins in Inflammation and Cancers Associated with Endometriosis. Biomolecules 10:2, pages 230.
Crossref
Qi Shao, Jing He, Zhiming Chen & Changping Wu. (2020) Prognostic role of galectins expression in patients with hepatic cancer. Medicine 99:15, pages e19622.
Crossref
Qiqing Sun, Yiyin Zhang, Mengqi Liu, Zeng Ye, Xianjun Yu, Xiaowu Xu & Yi Qin. (2019) Prognostic and diagnostic significance of galectins in pancreatic cancer: a systematic review and meta-analysis. Cancer Cell International 19:1.
Crossref
David J. R. FultonXueyi LiZsuzsanna BordanYusi WangKeyvan MahboubiR. Daniel RudicStephen HaighFeng ChenScott A. Barman. (2019) Galectin-3: A Harbinger of Reactive Oxygen Species, Fibrosis, and Inflammation in Pulmonary Arterial Hypertension. Antioxidants & Redox Signaling 31:14, pages 1053-1069.
Crossref
Alessandro Allegra, Vanessa Innao, Andrea Gaetano Allegra, Rossana Leanza & Caterina Musolino. (2019) Selective Inhibitors of Nuclear Export in the Treatment of Hematologic Malignancies. Clinical Lymphoma Myeloma and Leukemia 19:11, pages 689-698.
Crossref
Xiao-Ning Jiang, Yi-Fan Dang, Fu-Lian Gong & Xiu-Li Guo. (2019) Role and regulation mechanism of Gal-3 in non-small cell lung cancer and its potential clinical therapeutic significance. Chemico-Biological Interactions 309, pages 108724.
Crossref
Kamil Seyrek, Max Richter & Inna N. Lavrik. (2019) Decoding the sweet regulation of apoptosis: the role of glycosylation and galectins in apoptotic signaling pathways. Cell Death & Differentiation 26:6, pages 981-993.
Crossref
Bojana Stojanovic, Jelena Milovanovic, Aleksandar Arsenijevic, Bojan Stojanovic, Ivana Strazic Geljic, Nebojsa Arsenijevic, Stipan Jonjic, Miodrag L. Lukic & Marija Milovanovic. (2019) Galectin-3 Deficiency Facilitates TNF-α-Dependent Hepatocyte Death and Liver Inflammation in MCMV Infection. Frontiers in Microbiology 10.
Crossref
Qing Xiao, Fang‑Ling Zeng, Guo‑Yi Tang, Chun‑Yan Lei, Xian‑Xiang Zou, Xiao‑Le Liu, Bi‑Ling Peng, Shuang Qin & Hui‑Xian Li. (2019) Expression of galectin‑3 and apoptosis in placental villi from patients with missed abortion during early pregnancy. Experimental and Therapeutic Medicine.
Crossref
Peter P. Ruvolo. (2019) Galectins as regulators of cell survival in the leukemia niche. Advances in Biological Regulation 71, pages 41-54.
Crossref
Chang-Shuo Huang, Shye-Jye Tang, Mei-Hsuan Lee, Chien-Chih Chang Wang, Guang-Huan Sun & Kuang-Hui Sun. (2018) Galectin-3 promotes CXCR2 to augment the stem-like property of renal cell carcinoma. Journal of Cellular and Molecular Medicine 22:12, pages 5909-5918.
Crossref
Andrea Flores-Ibarra, Sabine Vértesy, Francisco J. Medrano, Hans-Joachim Gabius & Antonio Romero. (2018) Crystallization of a human galectin-3 variant with two ordered segments in the shortened N-terminal tail. Scientific Reports 8:1.
Crossref
Ujjawal H. Gandhi, William Senapedis, Erkan Baloglu, Thaddeus J. Unger, Ajai Chari, Dan Vogl & Robert F. Cornell. (2018) Clinical Implications of Targeting XPO1-mediated Nuclear Export in Multiple Myeloma. Clinical Lymphoma Myeloma and Leukemia 18:5, pages 335-345.
Crossref
Pratima Nangia-Makker, Victor Hogan & Avraham Raz. (2018) Galectin-3 and cancer stemness. Glycobiology 28:4, pages 172-181.
Crossref
Monica Fengsrud Brinchmann, Deepti Manjari Patel & Martin Haugmo Iversen. (2018) The Role of Galectins as Modulators of Metabolism and Inflammation. Mediators of Inflammation 2018, pages 1-11.
Crossref
Manu S. Singh, Salma N. Tammam, Maryam A. Shetab Boushehri & Alf Lamprecht. (2017) MDR in cancer: Addressing the underlying cellular alterations with the use of nanocarriers. Pharmacological Research 126, pages 2-30.
Crossref
Arjun Gupta, Jessica M. Saltarski, Michael A. White, Pier P. Scaglioni & David E. Gerber. (2017) Therapeutic Targeting of Nuclear Export Inhibition in Lung Cancer. Journal of Thoracic Oncology 12:9, pages 1446-1450.
Crossref
Xiaoge Gao, Jingjie Liu, Xiangye Liu, Liantao Li & Junnian Zheng. (2017) Cleavage and phosphorylation: important post-translational modifications of galectin-3. Cancer and Metastasis Reviews 36:2, pages 367-374.
Crossref
Sathisha U. Venkateshaiah, Mallikarjuna S. Eswaraiah, Harish Nayaka M. Annaiah & Shylaja M. Dharmesh. (2017) Antimetastatic pectic polysaccharide from Decalepis hamiltonii; galectin-3 inhibition and immune-modulation. Clinical & Experimental Metastasis 34:2, pages 141-154.
Crossref
Sofia N. Santos, Mara S. Junqueira, Guilherme Francisco, Manuel Vilanova, Ana Magalhães, Marcelo Dias Baruffi, Roger Chammas, Adrian L. Harris, Celso A. Reis & Emerson S. Bernardes. (2016) O-glycan sialylation alters galectin-3 subcellular localization and decreases chemotherapy sensitivity in gastric cancer. Oncotarget 7:50, pages 83570-83587.
Crossref
Gordana D. Radosavljevic, Jelena Pantic, Ivan Jovanovic, Miodrag L. Lukic & Nebojsa Arsenijevic. (2016) The Two Faces of Galectin-3: Roles in Various Pathological Conditions. Serbian Journal of Experimental and Clinical Research 17:3, pages 187-198.
Crossref
Hans Ippel, Michelle C Miller, Sabine Vértesy, Yi Zheng, F Javier Cañada, Dennis Suylen, Kimiko Umemoto, Cecilia Romanò, Tilman Hackeng, Guihua Tai, Hakon Leffler, Jürgen Kopitz, Sabine André, Dieter Kübler, Jesús Jiménez-Barbero, Stefan Oscarson, Hans-Joachim Gabius & Kevin H Mayo. (2016) Intra- and intermolecular interactions of human galectin-3: assessment by full-assignment-based NMR. Glycobiology 26:8, pages 888-903.
Crossref
Amit Mahipal & Mokenge Malafa. (2016) Importins and exportins as therapeutic targets in cancer. Pharmacology & Therapeutics 164, pages 135-143.
Crossref
Vinod Gopalan, Nassim Saremi, Emily Sullivan, Sadiul Kabir, Cu-Tai Lu, Ali Salajegheh, Melissa Leung, Robert Anthony Smith & Alfred King-yin Lam. (2016) The expression profiles of the galectin gene family in colorectal adenocarcinomas. Human Pathology 53, pages 105-113.
Crossref
Ana Carolina Ferreira Cardoso, Luciana Nogueira de Sousa Andrade, Silvina Odete Bustos & Roger Chammas. (2016) Galectin-3 Determines Tumor Cell Adaptive Strategies in Stressed Tumor Microenvironments. Frontiers in Oncology 6.
Crossref
Andrée-Anne Grosset, Marilyne Labrie, Maria Claudia Vladoiu, Einas M Yousef, Louis Gaboury & Yves St-Pierre. (2016) Galectin signatures contribute to the heterogeneity of breast cancer and provide new prognostic information and therapeutic targets. Oncotarget 7:14, pages 18183-18203.
Crossref
Małgorzata Pokrywka, Monika Bubka, Marcelina Janik, Ewa Pocheć, Dorota Hoja-Łukowicz & Anna Lityńska. (2016) Gal-3 does not suppress cisplatin-induced apoptosis in A-375 melanoma cells. Cell Biology International 40:4, pages 428-438.
Crossref
Aleksandar Arsenijevic, Marija Milovanovic, Jelena Milovanovic, Bojana Stojanovic, Natasa Zdravkovic, Patrick S.C. Leung, Fu-Tong Liu, M. Eric Gershwin & Miodrag L. Lukic. (2016) Deletion of Galectin-3 Enhances Xenobiotic Induced Murine Primary Biliary Cholangitis by Facilitating Apoptosis of BECs and Release of Autoantigens. Scientific Reports 6:1.
Crossref
Laura Di Magno, Alessio Basile, Sonia Coni, Simona Manni, Giulia Sdruscia, Davide D’Amico, Laura Antonucci, Paola Infante, Enrico De Smaele, Danilo Cucchi, Elisabetta Ferretti, Lucia Di Marcotullio, Isabella Screpanti & Gianluca Canettieri. (2016) The energy sensor AMPK regulates Hedgehog signaling in human cells through a unique Gli1 metabolic checkpoint. Oncotarget 7:8, pages 9538-9549.
Crossref
Claudia S. Priglinger, Jara Obermann, Christoph M. Szober, Juliane Merl-Pham, Uli Ohmayer, Jennifer Behler, Fabian Gruhn, Thomas C. Kreutzer, Christian Wertheimer, Arie Geerlof, Siegfried G. Priglinger & Stefanie M. Hauck. (2016) Epithelial-to-Mesenchymal Transition of RPE Cells In Vitro Confers Increased β1,6-N-Glycosylation and Increased Susceptibility to Galectin-3 Binding. PLOS ONE 11:1, pages e0146887.
Crossref
LILI QIAO, NING LIANG, JIAN XIE, HUI LUO, JINGXIN ZHANG, GUODONG DENG, YUPENG LI & JIANDONG ZHANG. (2016) Gene silencing of galectin-3 changes the biological behavior of Eca109 human esophageal cancer cells. Molecular Medicine Reports 13:1, pages 160-166.
Crossref
José Alexandre Ferreira, Andreia Peixoto, Manuel Neves, Cristiana Gaiteiro, Celso A. Reis, Yehuda G. Assaraf & Lúcio Lara Santos. (2016) Mechanisms of cisplatin resistance and targeting of cancer stem cells: Adding glycosylation to the equation. Drug Resistance Updates 24, pages 34-54.
Crossref
Wei Sun, Lian Li, Qingqing Yang, Wei Shan, Zhirong Zhang & Yuan Huang. (2015) G3-C12 Peptide Reverses Galectin-3 from Foe to Friend for Active Targeting Cancer Treatment. Molecular Pharmaceutics 12:11, pages 4124-4136.
Crossref
Jo Ishizawa, Kensuke Kojima, Numsen HailJr.Jr., Yoko Tabe & Michael Andreeff. (2015) Expression, function, and targeting of the nuclear exporter chromosome region maintenance 1 (CRM1) protein. Pharmacology & Therapeutics 153, pages 25-35.
Crossref
Janusa Maria Muniz, Cláudia Renata Bibiano Borges, Marcela Beghini, Marcelo Sivieri de Araújo, Polyanna Miranda Alves, Lilian Margareth Biagioni de Lima, Sanívia Aparecida de Lima Pereira, Ruchele Dias Nogueira, Marcelo Henrique Napimoga, Virmondes RodriguesJrJr & Denise Bertulucci Rocha Rodrigues. (2015) Galectin-9 as an important marker in the differential diagnosis between oral squamous cell carcinoma, oral leukoplakia and oral lichen planus. Immunobiology 220:8, pages 1006-1011.
Crossref
Hafiz AhmedDina M. M. Alsadek. (2015) Galectin-3 as a Potential Target to Prevent Cancer Metastasis. Clinical Medicine Insights: Oncology 9, pages CMO.S29462.
Crossref
Connie M. Arthur, Marcelo Dias Baruffi, Richard D. Cummings & Sean R. Stowell. 2015. Galectins. Galectins 1 35 .
Jun Ma, Yilong Yao, Ping Wang, Yunhui Liu, Lini Zhao, Zhiqing Li, Zhen Li & Yixue Xue. (2014) MiR-152 functions as a tumor suppressor in glioblastoma stem cells by targeting Krüppel-like factor 4. Cancer Letters 355:1, pages 85-95.
Crossref
Rafael Yamashita Ikemori, Camila Maria Longo Machado, Karina Mie Furuzawa, Suely Nonogaki, Eduardo Osinaga, Kazuo Umezawa, Marcelo Alex de Carvalho, Liana Verinaud & Roger Chammas. (2014) Galectin-3 Up-Regulation in Hypoxic and Nutrient Deprived Microenvironments Promotes Cell Survival. PLoS ONE 9:11, pages e111592.
Crossref
Yosuke Harazono, Dhong Hyo Kho, Vitaly Balan, Kosei Nakajima, Tianpeng Zhang, Victor Hogan & Avraham Raz. (2014) Galectin-3 leads to attenuation of apoptosis through Bax heterodimerization in human thyroid carcinoma cells. Oncotarget 5:20, pages 9992-10001.
Crossref
Young Wha Koh, Se Jin Jung, Chan-Sik Park, Dok Hyun Yoon, Cheolwon Suh & Jooryung Huh. (2014) LGALS3 as a prognostic factor for classical Hodgkin's lymphoma. Modern Pathology 27:10, pages 1338-1344.
Crossref
Tatsuyoshi Funasaka, Avraham Raz & Pratima Nangia-Makker. (2014) Nuclear transport of galectin-3 and its therapeutic implications. Seminars in Cancer Biology 27, pages 30-38.
Crossref
Joel G. Turner, Jana Dawson, Christopher L. Cubitt, Rachid Baz & Daniel M. Sullivan. (2014) Inhibition of CRM1-dependent nuclear export sensitizes malignant cells to cytotoxic and targeted agents. Seminars in Cancer Biology 27, pages 62-73.
Crossref
H Sun, N Hattori, W Chien, Q Sun, M Sudo, G L E-Ling, L Ding, S L Lim, S Shacham, M Kauffman, T Nakamaki & H P Koeffler. (2014) KPT-330 has antitumour activity against non-small cell lung cancer. British Journal of Cancer 111:2, pages 281-291.
Crossref
Martin Stöter, Marc Krüger, George Banting, Doris Henne-Bruns & Uwe Knippschild. (2014) Microtubules Depolymerization Caused by the CK1 Inhibitor IC261 May Be Not Mediated by CK1 Blockage. PLoS ONE 9:6, pages e100090.
Crossref
Anneliese Fortuna-Costa, Angélica M. Gomes, Eliene O. Kozlowski, Mariana P. Stelling & Mauro S. G. Pavão. (2014) Extracellular Galectin-3 in Tumor Progression and Metastasis. Frontiers in Oncology 4.
Crossref
David S.P. Tan, Philippe L. Bedard, John Kuruvilla, Lillian L. Siu & Albiruni R. Abdul Razak. (2014) Promising SINEs for Embargoing Nuclear–Cytoplasmic Export as an Anticancer Strategy. Cancer Discovery 4:5, pages 527-537.
Crossref
Y. Harazono, K. Nakajima & A. Raz. (2013) Why anti-Bcl-2 clinical trials fail: a solution. Cancer and Metastasis Reviews 33:1, pages 285-294.
Crossref
Richard Hill, Bastien Cautain, Nuria de Pedro & Wolfgang Link. (2013) Targeting nucleocytoplasmic transport in cancer therapy. Oncotarget 5:1, pages 11-28.
Crossref
M. Álvaro Berbís, Sabine André, F. Javier Cañada, Rüdiger Pipkorn, Hans Ippel, Kevin H. Mayo, Dieter Kübler, Hans-Joachim Gabius & Jesús Jiménez-Barbero. (2014) Peptides derived from human galectin-3 N-terminal tail interact with its carbohydrate recognition domain in a phosphorylation-dependent manner. Biochemical and Biophysical Research Communications 443:1, pages 126-131.
Crossref
Joachim Bischof, Sven-Jannis Randoll, Nadine Süßner, Doris Henne-Bruns, Lorenzo A. Pinna & Uwe Knippschild. (2013) CK1δ Kinase Activity Is Modulated by Chk1-Mediated Phosphorylation. PLoS ONE 8:7, pages e68803.
Crossref
Tamara Saksida, Ivana Nikolic, Milica Vujicic, Ulf J. Nilsson, Hakon Leffler, Miodrag L. Lukic, Ivana Stojanovic & Stanislava Stosic-Grujicic. (2013) Galectin-3 deficiency protects pancreatic islet cells from cytokine-triggered apoptosis in vitro. Journal of Cellular Physiology 228:7, pages 1568-1576.
Crossref
Tatsuyoshi Funasaka, Vitaly Balan, Avraham Raz & Richard W. Wong. (2013) Nucleoporin Nup98 mediates galectin-3 nuclear-cytoplasmic trafficking. Biochemical and Biophysical Research Communications 434:1, pages 155-161.
Crossref
Andréia Neves Comodo, Andre Luis Lacerda Bachi, Maria Fernanda Soares, Marcello Franco & Vicente de Paulo Castro Teixeira. (2013) Galectin-3 expression favors metastasis in murine melanoma. Advances in Bioscience and Biotechnology 04:10, pages 55-62.
Crossref
Lili Yu & Rudolf A. de Boer. 2013. Cardiac Remodeling. Cardiac Remodeling 97 111 .
Rosa LapalombellaQingxiang SunKatie WilliamsLarissa TangemanShruti JhaYiming ZhongVirginia GoettlEmilia MahoneyCaroline BerglundSneha GuptaAlicia FarmerRajeswaran ManiAmy J. Johnson, David Lucas, Xiaokui MoDirk Daelemans, Vincent Sandanayaka, Sharon Shechter, Dilara McCauley, Sharon Shacham, Michael Kauffman, Yuh Min ChookJohn C. Byrd. (2012) Selective inhibitors of nuclear export show that CRM1/XPO1 is a target in chronic lymphocytic leukemia. Blood 120:23, pages 4621-4634.
Crossref
Russell R. Braeuer, Maya Zigler, Takafumi Kamiya, Andrey S. Dobroff, Li Huang, Woonyoung Choi, David J. McConkey, Einav Shoshan, Aaron K. Mobley, Renduo Song, Avraham Raz & Menashe Bar-Eli. (2012) Galectin-3 Contributes to Melanoma Growth and Metastasis via Regulation of NFAT1 and Autotaxin. Cancer Research 72:22, pages 5757-5766.
Crossref
Veronica Veschi, Marialaura Petroni, Beatrice Cardinali, Carlo Dominici, Isabella Screpanti, Luigi Frati, Armando Bartolazzi, Alberto Gulino & Giuseppe Giannini. (2012) Galectin-3 Impairment of MYCN-Dependent Apoptosis-Sensitive Phenotype Is Antagonized by Nutlin-3 in Neuroblastoma Cells. PLoS ONE 7:11, pages e49139.
Crossref
Zhenzhen Hu, Xiuqin Jiang, Ying Xu, Nan Lu, Weizhi Wang, Jie Luo, Han Zou, Datong Zheng & Xing Feng. (2012) Downregulation of galectin-3 by EGF mediates the apoptosis of HepG2 cells. Molecular and Cellular Biochemistry 369:1-2, pages 157-165.
Crossref
Joel G. Turner, Jana Dawson & Daniel M. Sullivan. (2012) Nuclear export of proteins and drug resistance in cancer. Biochemical Pharmacology 83:8, pages 1021-1032.
Crossref
Leonardo Mirandola, Yuefei Yu, Constance M. John, Marjorie Jenkins, Everardo Cobos & Maurizio Chiriva-Internati. 2012. Galectins and Disease Implications for Targeted Therapeutics. Galectins and Disease Implications for Targeted Therapeutics 289 307 .
Gary A. Jarvis, Leonardo Mirandola, Yu Yuefei, Everardo Cobos, Maurizio Chiriva-Internati & Constance M. John. 2012. Galectins and Disease Implications for Targeted Therapeutics. Galectins and Disease Implications for Targeted Therapeutics 195 232 .
Herwig M. Strik & Matthias Ocker. 2012. Galectins and Disease Implications for Targeted Therapeutics. Galectins and Disease Implications for Targeted Therapeutics 171 180 .
James C. Byrd, Nachman Mazurek & Robert S. Bresalier. 2012. Galectins and Disease Implications for Targeted Therapeutics. Galectins and Disease Implications for Targeted Therapeutics 137 151 .
Huan Yang, Caixia Lei & Wei Zhang. (2012) Expression of galectin-3 in mouse endometrium and its effect during embryo implantation. Reproductive BioMedicine Online 24:1, pages 116-122.
Crossref
Fanny Delegrange, Mattia Matasci, Lucia Baldi & Florian M. Wurm. 2012. Proceedings of the 21st Annual Meeting of the European Society for Animal Cell Technology (ESACT), Dublin, Ireland, June 7-10, 2009. Proceedings of the 21st Annual Meeting of the European Society for Animal Cell Technology (ESACT), Dublin, Ireland, June 7-10, 2009 31 35 .
G. S. GuptaAnita Gupta. 2012. Animal Lectins: Form, Function and Clinical Applications. Animal Lectins: Form, Function and Clinical Applications 291 310 .
Çiğdem Berna Ege, Metin Akbulut, Osman Zekioğlu & Necmettin Özdemir. (2010) Investigation of galectin-3 and heparanase in endometrioid and serous carcinomas of the endometrium and correlation with known predictors of survival. Archives of Gynecology and Obstetrics 284:5, pages 1231-1239.
Crossref
M. Buljan, M. Šitum, D. Tomas, M. Milošević & B. Krušlin. (2011) Prognostic value of galectin-3 in primary cutaneous melanoma. Journal of the European Academy of Dermatology and Venereology 25:10, pages 1174-1181.
Crossref
Nachman Mazurek, James C. Byrd, Yunjie Sun, Suguru Ueno & Robert S. Bresalier. (2011) A galectin-3 sequence polymorphism confers TRAIL sensitivity to human breast cancer cells. Cancer 117:19, pages 4375-4380.
Crossref
Chung Yeng Looi, Miki Imanishi, Satoshi Takaki, Miki Sato, Natsuko Chiba, Yoji Sasahara, Shiroh Futaki, Shigeru Tsuchiya & Satoru Kumaki. (2011) Octa-Arginine Mediated Delivery of Wild-Type Lnk Protein Inhibits TPO-Induced M-MOK Megakaryoblastic Leukemic Cell Growth by Promoting Apoptosis. PLoS ONE 6:8, pages e23640.
Crossref
Joachim Bischof, Adrienne Müller, Miriam Fänder, Uwe Knippschild & Dietmar Fischer. (2011) Neurite Outgrowth of Mature Retinal Ganglion Cells and PC12 Cells Requires Activity of CK1δ and CK1ε. PLoS ONE 6:6, pages e20857.
Crossref
Tsutomu Kobayashi, Tatsuo Shimura, Toshiki Yajima, Norio Kubo, Kenichiro Araki, Wataru Wada, Soichi Tsutsumi, Hideki Suzuki, Hiroyuki Kuwano & Avraham Raz. (2011) Transient silencing of galectin-3 expression promotes both in vitro and in vivo drug-induced apoptosis of human pancreatic carcinoma cells. Clinical & Experimental Metastasis 28:4, pages 367-376.
Crossref
Daryl M. Okamura, Katie Pasichnyk, Jesus M. Lopez-Guisa, Sarah Collins, Daniel K. Hsu, Fu-Tong Liu & Allison A. Eddy. (2011) Galectin-3 preserves renal tubules and modulates extracellular matrix remodeling in progressive fibrosis. American Journal of Physiology-Renal Physiology 300:1, pages F245-F253.
Crossref
Fu-Tong Liu, Ri-Yao Yang, Jun Saegusa, Huan-Yuan Chen & Daniel K. Hsu. 2011. The Molecular Immunology of Complex Carbohydrates-3. The Molecular Immunology of Complex Carbohydrates-3 431 442 .
Lihui Wu, Qianlei Zhao, Xuchao Zhu, Min Peng, Chenyou Jia, Wei Wu, Jing Zheng & Xing Zhong Wu. (2010) A Novel Function of MicroRNA Let-7d in Regulation of Galectin-3 Expression in Attention Deficit Hyperactivity Disorder Rat Brain. Brain Pathology 20:6, pages 1042-1054.
Crossref
K. C. Haudek, R. J. Patterson & J. L. Wang. (2010) SR proteins and galectins: what's in a name?. Glycobiology 20:10, pages 1199-1207.
Crossref
Vitaly Balan, Pratima Nangia-Makker, Young Suk Jung, Yi Wang & Avraham Raz. (2010) Galectin-3: A novel substrate for c-Abl kinase. Biochimica et Biophysica Acta (BBA) - Molecular Cell Research 1803:10, pages 1198-1205.
Crossref
Marcelo HillDaniel MazalVerónica Andrea BironLaura PereiraLuis Ubillos, Edgardo Berriel, Hafiz AhmedTeresa Freire, Mariella Rondán, Gerardo R. VastaFu-Tong LiuMaría Mercedes IglesiasEduardo Osinaga. (2010) A Novel Clinically Relevant Animal Model for Studying Galectin-3 and Its Ligands During Colon Carcinogenesis. Journal of Histochemistry & Cytochemistry 58:6, pages 553-565.
Crossref
Natalia Díez-Revuelta, Silvia Velasco, Sabine André, Herbert Kaltner, Dieter Kübler, Hans-Joachim Gabius & José Abad-Rodríguez. (2010) Phosphorylation of adhesion- and growth-regulatory human galectin-3 leads to the induction of axonal branching by local membrane L1 and ERM redistribution. Journal of Cell Science 123:5, pages 671-681.
Crossref
Kevin C. Haudek, Kimberly J. Spronk, Patricia G. Voss, Ronald J. Patterson, John L. Wang & Eric J. Arnoys. (2010) Dynamics of galectin-3 in the nucleus and cytoplasm. Biochimica et Biophysica Acta (BBA) - General Subjects 1800:2, pages 181-189.
Crossref
Anja C. Utz, Heidrun Hirner, Annette Blatz, Andreas Hillenbrand, Bernhard Schmidt, Wolfgang Deppert, Doris Henne-Bruns, Dietmar Fischer, Dietmar R. Thal, Frank Leithäuser & Uwe Knippschild. (2009) Analysis of Cell Type-specific Expression of CK1ε in Various Tissues of Young Adult BALB/c Mice and in Mammary Tumors of SV40 T-Ag-transgenic Mice. Journal of Histochemistry & Cytochemistry 58:1, pages 1-15.
Crossref
Markus Weber, Daniela Sporrer, Johanna Weigert, Josef Wanninger, Markus Neumeier, Sylvia Wurm, Fabian Stögbauer, Andrea Kopp, Margarita Bala, Andreas Schäffler & Christa Buechler. (2009) Adiponectin downregulates galectin-3 whose cellular form is elevated whereas its soluble form is reduced in type 2 diabetic monocytes. FEBS Letters 583:22, pages 3718-3724.
Crossref
Sopit Wongkham, Mutita Junking, Chaisiri Wongkham, Banchob Sripa, Siri Chur-in & Norie Araki. (2009) Suppression of galectin-3 expression enhances apoptosis and chemosensitivity in liver fluke-associated cholangiocarcinoma. Cancer Science 100:11, pages 2077-2084.
Crossref
Chi-Iou Lin, Edward E. Whang, David B. Donner, Xiaofeng Jiang, Brendan D. Price, Adelaide M. Carothers, Tamara Delaine, Hakon Leffler, Ulf J. Nilsson, Vania Nose, Francis D. Moore,Jr.Jr. & Daniel T. Ruan. (2009) Galectin-3 Targeted Therapy with a Small Molecule Inhibitor Activates Apoptosis and Enhances Both Chemosensitivity and Radiosensitivity in Papillary Thyroid Cancer. Molecular Cancer Research 7:10, pages 1655-1662.
Crossref
Joel G. Turner, Douglas C. Marchion, Jana L. Dawson, Michael F. Emmons, Lori A. Hazlehurst, Peter Washausen & Daniel M. Sullivan. (2009) Human Multiple Myeloma Cells Are Sensitized to Topoisomerase II Inhibitors by CRM1 Inhibition. Cancer Research 69:17, pages 6899-6905.
Crossref
Huan-Yuan ChenAgnes FerminSantosh VardhanaI-Chun WengKin Fong Robin LoEn-Yuh Chang, Emanual Maverakis, Ri-Yao YangDaniel K HsuMichael L. DustinFu-Tong Liu. (2009) Galectin-3 negatively regulates TCR-mediated CD4 + T-cell activation at the immunological synapse . Proceedings of the National Academy of Sciences 106:34, pages 14496-14501.
Crossref
Monique van Scherpenzeel, Ed E. Moret, Lluis Ballell, Rob M. J. Liskamp, Ulf J. Nilsson, Hakon Leffler & Roland J. Pieters. (2009) Synthesis and Evaluation of New Thiodigalactoside-Based Chemical Probes to Label Galectin-3. ChemBioChem 10:10, pages 1724-1733.
Crossref
Ai Matsuura, Junichi Tsukada, Takamitsu Mizobe, Takehiro Higashi, Fumihiko Mouri, Rena Tanikawa, Akira Yamauchi, Mitsuomi Hirashima & Yoshiya Tanaka. (2009) Intracellular galectin-9 activates inflammatory cytokines in monocytes. Genes to Cells 14:4, pages 511-521.
Crossref
P. Szabo, T. K. Dam, K. Smetana Jr, B. Dvořánková, D. Kübler, C. F. Brewer & H.-J. Gabius. (2009) Phosphorylated Human Lectin Galectin-3: Analysis of Ligand Binding by Histochemical Monitoring of Normal/Malignant Squamous Epithelia and by Isothermal Titration Calorimetry. Anatomia, Histologia, Embryologia 38:1, pages 68-75.
Crossref
Yoko Funakoshi & Tadashi Suzuki. (2009) Glycobiology in the cytosol: The bitter side of a sweet world. Biochimica et Biophysica Acta (BBA) - General Subjects 1790:2, pages 81-94.
Crossref
Jürgen Löhler, Heidrun Hirner, Bernhard Schmidt, Klaus Kramer, Dietmar Fischer, Dietmar R. Thal, Frank Leithäuser & Uwe Knippschild. (2009) Immunohistochemical Characterisation of Cell-Type Specific Expression of CK1δ in Various Tissues of Young Adult BALB/c Mice. PLoS ONE 4:1, pages e4174.
Crossref
Sung-Hye Park, Hye Sook Min, Bomi Kim, Jaekyung Myung & Sun Ha Paek. (2008) Galectin-3: A useful biomarker for differential diagnosis of brain tumors. Neuropathology 28:5, pages 497-506.
Crossref
Duck-Woo Kim, Kyung Hee Kim, Byong Chul Yoo, Sung-Hye Hong, Yong Chul Lim, Young-Kyoung Shin & Jae-Gahb Park. (2008) Identification of mitochondrial F 1 F 0 -ATP synthase interacting with galectin-3 in colon cancer cells . Cancer Science.
Crossref
Jun Saegusa, Daniel K. Hsu, Wei Liu, Ichiro Kuwabara, Yasuko Kuwabara, Lan Yu & Fu-Tong Liu. (2008) Galectin-3 Protects Keratinocytes from UVB-Induced Apoptosis by Enhancing AKT Activation and Suppressing ERK Activation. Journal of Investigative Dermatology 128:10, pages 2403-2411.
Crossref
Ruby Shalom-Feuerstein, Sarah J. Plowman, Barak Rotblat, Nicholas Ariotti, Tianhai Tian, John F. Hancock & Yoel Kloog. (2008) K-Ras Nanoclustering Is Subverted by Overexpression of the Scaffold Protein Galectin-3. Cancer Research 68:16, pages 6608-6616.
Crossref
Ri-Yao Yang, Gabriel A. Rabinovich & Fu-Tong Liu. (2008) Galectins: structure, function and therapeutic potential. Expert Reviews in Molecular Medicine 10.
Crossref
Yoshihiro Suzuki, Toshio Inoue, Tetsuro Yoshimaru & Chisei Ra. (2008) Galectin-3 but not galectin-1 induces mast cell death by oxidative stress and mitochondrial permeability transition. Biochimica et Biophysica Acta (BBA) - Molecular Cell Research 1783:5, pages 924-934.
Crossref
P Demetter, N Nagy, B Martin, A Mathieu, P Dumont, C Decaestecker & I Salmon. (2008) The galectin family and digestive disease. The Journal of Pathology 215:1, pages 1-12.
Crossref
Dieter Kübler, Chien-Wen Hung, Tarun K. Dam, Jürgen Kopitz, Sabine André, Herbert Kaltner, Michaela Lohr, Joachim C. Manning, Lizhong He, Hui Wang, Anton Middelberg, C. Fred Brewer, Jennifer Reed, Wolf-Dieter Lehmann & Hans-Joachim Gabius. (2008) Phosphorylated human galectin-3: Facile large-scale preparation of active lectin and detection of structural changes by CD spectroscopy. Biochimica et Biophysica Acta (BBA) - General Subjects 1780:4, pages 716-722.
Crossref
Mutita Junking, Chaisiri Wongkham, Banchob Sripa, Kanlayanee Sawanyawisuth, Norie Araki & Sopit Wongkham. (2008) Decreased expression of galectin-3 is associated with metastatic potential of liver fluke-associated cholangiocarcinoma. European Journal of Cancer 44:4, pages 619-626.
Crossref
Manabu Sakaki, Natsuo Oka, Ryoichi Nakanishi, Kunihisa Yamaguchi, Tomoharu Fukumori & Hiro-omi Kanayama. (2008) Serum level of galectin-3 in human bladder cancer. The Journal of Medical Investigation 55:1,2, pages 127-132.
Crossref
Gabriel A. Rabinovich & Fu-Tong Liu. 2008. Tumor-Induced Immune Suppression. Tumor-Induced Immune Suppression 235 258 .
Jinshan Wang, Peter Gutierrez, Nathan Edwards & Catherine Fenselau. (2007) Integration of 18 O Labeling and Solution Isoelectric Focusing in a Shotgun Analysis of Mitochondrial Proteins . Journal of Proteome Research 6:12, pages 4601-4607.
Crossref
Fabiana H. M. de Melo, Diego Butera, Raphael S. Medeiros, Luciana N. de S. Andrade, Suely Nonogaki, Fernando A. Soares, Richard A. Alvarez, Ana M. Moura da Silva & Roger Chammas. (2016) Biological Applications of a Chimeric Probe for the Assessment of Galectin-3 Ligands. Journal of Histochemistry & Cytochemistry 55:10, pages 1015-1026.
Crossref
Selvi Ramasamy, Sekhar Duraisamy, Sergei Barbashov, Takeshi Kawano, Surender Kharbanda & Donald Kufe. (2007) The MUC1 and Galectin-3 Oncoproteins Function in a MicroRNA-Dependent Regulatory Loop. Molecular Cell 27:6, pages 992-1004.
Crossref
Sven Saussez, Isabelle Camby, Gerard Toubeau & Robert Kiss. (2007) Galectins as modulators of tumor progression in head and neck squamous cell carcinomas. Head & Neck 29:9, pages 874-884.
Crossref
Kim D. Johnson, Olga V. Glinskii, Valeri V. Mossine, James R. Turk, Thomas P. Mawhinney, Douglas C. Anthony, Carolyn J. Henry, Virginia H. Huxley, Gennadi V. Glinsky, Kenneth J. Pienta, Avraham Raz & Vladislav V. Glinsky. (2007) Galectin-3 as a Potential Therapeutic Target in Tumors Arising from Malignant Endothelia. Neoplasia 9:8, pages 662-670.
Crossref
Nachman Mazurek, Yun Jie Sun, Kai-Feng Liu, Michael Z. Gilcrease, Wendy Schober, Pratima Nangia-Makker, Avraham Raz & Robert S. Bresalier. (2007) Phosphorylated Galectin-3 Mediates Tumor Necrosis Factor-related Apoptosis-inducing Ligand Signaling by Regulating Phosphatase and Tensin Homologue Deleted on Chromosome 10 in Human Breast Carcinoma Cells. Journal of Biological Chemistry 282:29, pages 21337-21348.
Crossref
Kivia Linhares Ferrazzo, Sergio Melo AlvesJr.Jr., Elisa Santos, Marilia Trierveiler Martins & Suzana Machado de Sousa. (2007) Galectin-3 immunoprofile in adenoid cystic carcinoma and polymorphous low-grade adenocarcinoma of salivary glands. Oral Oncology 43:6, pages 580-585.
Crossref
Tomoharu Fukumori, Hiro-omi Kanayama & Avraham Raz. (2007) The role of galectin-3 in cancer drug resistance. Drug Resistance Updates 10:3, pages 101-108.
Crossref
Rohit G. Saldanha, Mark P. Molloy, Khalil Bdeir, Douglas B. Cines, Xiaomin Song, Pauliina M. Uitto, Paul H. Weinreb, Shelia M. Violette & Mark S. Baker. (2007) Proteomic Identification of Lynchpin Urokinase Plasminogen Activator Receptor Protein Interactions Associated with Epithelial Cancer Malignancy. Journal of Proteome Research 6:3, pages 1016-1028.
Crossref
James R. Davis, Mudit Kakar & Carol S. Lim. (2006) Controlling Protein Compartmentalization to Overcome Disease. Pharmaceutical Research 24:1, pages 17-27.
Crossref
Susumu Nakahara, Victor Hogan, Hidenori Inohara & Avraham Raz. (2006) Importin-mediated Nuclear Translocation of Galectin-3. Journal of Biological Chemistry 281:51, pages 39649-39659.
Crossref
Victor G. Prieto, Alexandra A. Mourad-Zeidan, Vladislava Melnikova, Marcella M. Johnson, Adriana Lopez, A. Hafeez Diwan, Alexander J.F. Lazar, Steven S. Shen, Peter S. Zhang, Jon A. Reed, Jeffrey E. Gershenwald, Avraham Raz & Menashe Bar-Eli. (2006) Galectin-3 Expression Is Associated with Tumor Progression and Pattern of Sun Exposure in Melanoma. Clinical Cancer Research 12:22, pages 6709-6715.
Crossref
Natsuo Oka, Shuji Tanimoto, Ryuichi Taue, Hiroyoshi Nakatsuji, Tomoteru Kishimoto, Hirofumi Izaki, Tomoharu Fukumori, Masayuki Takahashi, Masaaki Nishitani & Hiro-omi Kanayama. (2006) Role of phosphatidylinositol-3 kinase/Akt pathway in bladder cancer cell apoptosis induced by tumor necrosis factor-related apoptosis-inducing ligand. Cancer Science 97:10, pages 1093-1098.
Crossref
Jitka Bartošová, Kateřina Kuželová, Michaela Pluskalová, Iuri Marinov, Petr Halada & Zdeňka Gašová. (2006) UVA-activated 8-methoxypsoralen (PUVA) causes G2/M cell cycle arrest in Karpas 299 T-lymphoma cells. Journal of Photochemistry and Photobiology B: Biology 85:1, pages 39-48.
Crossref
Frank Ocklenburg, Darius Moharregh-Khiabani, Robert Geffers, Viktoria Janke, Susanne Pfoertner, Henk Garritsen, Lothar Groebe, Juergen Klempnauer, Kurt E J Dittmar, Siegfried Weiss, Jan Buer & Michael Probst-Kepper. (2006) UBD, a downstream element of FOXP3, allows the identification of LGALS3, a new marker of human regulatory T cells. Laboratory Investigation 86:7, pages 724-737.
Crossref
Junko Nio, Hiromi Takahashi-Iwanaga, Masami Morimatsu, Yasuhiro Kon & Toshihiko Iwanaga. (2006) Immunohistochemical and in situ hybridization analysis of galectin-3, a β-galactoside binding lectin, in the urinary system of adult mice. Histochemistry and Cell Biology 126:1, pages 45-56.
Crossref
Mariana Rodríguez Zubieta, David Furman, Marcela Barrio, Alicia Inés Bravo, Enzo Domenichini & José Mordoh. (2006) Galectin-3 Expression Correlates with Apoptosis of Tumor-Associated Lymphocytes in Human Melanoma Biopsies. The American Journal of Pathology 168:5, pages 1666-1675.
Crossref
Jerka Dumic, Sanja Dabelic & Mirna Flögel. (2006) Galectin-3: An open-ended story. Biochimica et Biophysica Acta (BBA) - General Subjects 1760:4, pages 616-635.
Crossref
Tomoharu Fukumori, Natsuo Oka, Yukinori Takenaka, Pratima Nangia-Makker, Essam Elsamman, Toshinori Kasai, Masayuki Shono, Hiro-omi Kanayama, Julie Ellerhorst, Reuben Lotan & Avraham Raz. (2006) Galectin-3 Regulates Mitochondrial Stability and Antiapoptotic Function in Response to Anticancer Drug in Prostate Cancer. Cancer Research 66:6, pages 3114-3119.
Crossref
Laurent IngrassiaProsper NshimyumukizaJanique DewelleFlorence LefrancLise WlodarczakStéphanie ThomasGwenaël DielieChristelle ChironChantal ZeddePierre TisnèsRob van SoestJean-Claude BraekmanFrancis DarroRobert Kiss. (2006) A Lactosylated Steroid Contributes in Vivo Therapeutic Benefits in Experimental Models of Mouse Lymphoma and Human Glioblastoma. Journal of Medicinal Chemistry 49:5, pages 1800-1807.
Crossref
Arndt Vogel, Joseph E. Aslan, Holger Willenbring, Christian Klein, Milton Finegold, Howard Mount, Gary Thomas & Markus Grompe. (2006) Sustained Phosphorylation of Bid Is a Marker for Resistance to Fas-Induced Apoptosis During Chronic Liver Diseases. Gastroenterology 130:1, pages 104-119.
Crossref
Daniel K. Hsu, Ri‐Yao Yang & Fu‐Tong Liu. 2006. Functional Glycomics. Functional Glycomics 256 273 .
Nachman Mazurek, Yun Jie Sun, Janet E. Price, Latha Ramdas, Wendy Schober, Pratima Nangia-Makker, James C. Byrd, Avraham Raz & Robert S. Bresalier. (2005) Phosphorylation of Galectin-3 Contributes to Malignant Transformation of Human Epithelial Cells via Modulation of Unique Sets of Genes. Cancer Research 65:23, pages 10767-10775.
Crossref
Shumei Song, James C. Byrd, Nachman Mazurek, Kaifeng Liu, Ja Seok Koo & Robert S. Bresalier. (2005) Galectin-3 Modulates MUC2 Mucin Expression in Human Colon Cancer Cells at the Level of Transcription via AP-1 Activation. Gastroenterology 129:5, pages 1581-1591.
Crossref
Dharminder Chauhan, Guilan Li, Klaus Podar, Teru Hideshima, Paola Neri, Deli He, Nicholas Mitsiades, Paul Richardson, Yan Chang, Joanne Schindler, Bradley Carver & Kenneth C. Anderson. (2005) A Novel Carbohydrate-Based Therapeutic GCS-100 Overcomes Bortezomib Resistance and Enhances Dexamethasone-Induced Apoptosis in Multiple Myeloma Cells. Cancer Research 65:18, pages 8350-8358.
Crossref
Natsuo Oka, Susumu Nakahara, Yukinori Takenaka, Tomoharu Fukumori, Victor Hogan, Hiro-omi Kanayama, Takashi Yanagawa & Avraham Raz. (2005) Galectin-3 Inhibits Tumor Necrosis Factor–Related Apoptosis-Inducing Ligand–Induced Apoptosis by Activating Akt in Human Bladder Carcinoma Cells. Cancer Research 65:17, pages 7546-7553.
Crossref
Anne Mathieu, Isabelle Saal, Aline Vuckovic, Valérie Ransy, Pierre Vereerstraten, Herbert Kaltner, Hans-Joachim Gabius, Robert Kiss, Christine Decaestecker, Isabelle Salmon & Myriam Remmelink. (2005) Nuclear galectin-3 expression is an independent predictive factor of recurrence for adenocarcinoma and squamous cell carcinoma of the lung. Modern Pathology 18:9, pages 1264-1271.
Crossref
Ruby Shalom-Feuerstein, Tomer Cooks, Avraham Raz & Yoel Kloog. (2005) Galectin-3 Regulates a Molecular Switch from N-Ras to K-Ras Usage in Human Breast Carcinoma Cells. Cancer Research 65:16, pages 7292-7300.
Crossref
Tatsuo Shimura, Yukinori Takenaka, Tomoharu Fukumori, Soichi Tsutsumi, Kohji Okada, Victor Hogan, Akira Kikuchi, Hiroyuki Kuwano & Avraham Raz. (2005) Implication of Galectin-3 in Wnt Signaling. Cancer Research 65:9, pages 3535-3537.
Crossref
S. Nakahara, N. Oka & A. Raz. (2005) On the role of galectin-3 in cancer apoptosis. Apoptosis 10:2, pages 267-275.
Crossref
Daniel K. Hsu, Ichiro Kuwabara & Fu-Tong Liu. (2005) Galectin-3 and Regulation of Cell Function. Transfusion Medicine and Hemotherapy 32:2, pages 83-96.
Crossref
Fu-Tong Liu & Gabriel A. Rabinovich. (2005) Galectins as modulators of tumour progression. Nature Reviews Cancer 5:1, pages 29-41.
Crossref
Sven Saussez, Denis Nonclercq, Guy Laurent, Rudy Wattiez, Sabine Andr�, Herbert Kaltner, Hans-Joachim Gabius, Robert Kiss & G�rard Toubeau. (2004) Toward functional glycomics by localization of tissue lectins: immunohistochemical galectin fingerprinting during diethylstilbestrol-induced kidney tumorigenesis in male Syrian hamster. Histochemistry and Cell Biology 123:1, pages 29-41.
Crossref
Stéphane Califice, Vincent Castronovo, Marc Bracke & Frédéric van den Brûle. (2004) Dual activities of galectin-3 in human prostate cancer: tumor suppression of nuclear galectin-3 vs tumor promotion of cytoplasmic galectin-3. Oncogene 23:45, pages 7527-7536.
Crossref

Reprints and Corporate Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

To request a reprint or corporate permissions for this article, please click on the relevant link below:

Order Reprints Request Corporate Permissions

Academic Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

Obtain permissions instantly via Rightslink by clicking on the button below:

Request Academic Permissions

If you are unable to obtain permissions via Rightslink, please complete and submit this Permissions form. For more information, please visit our Permissions help page.

Related research

People also read lists articles that other readers of this article have read.

Recommended articles lists articles that we recommend and is powered by our AI driven recommendation engine.

Cited by lists all citing articles based on Crossref citations.
Articles with the Crossref icon will open in a new tab.